Antagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
نویسندگان
چکیده
منابع مشابه
Antagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
Helicobacter pylori infection invariably induces chronic active gastritis which can give rise to serious consequences such as peptic ulcer and gastric malignancies. Generally accepted indications for treatment are H pylori associated peptic ulcer disease and early stages of low grade mucosa associated lymphoid tissue lymphoma of the stomach. In contrast, treatment of H pylori in patients with g...
متن کاملAntagonist: should we eradicate Helicobacter pylori in non-ulcer dyspepsia?
EPIDEMIOLOGICAL STUDIES Forty two epidemiological studies compared the prevalence of H pylori infection in dyspeptic patients and asymptomatic controls (see website fig 1). Meaningful studies should use the following design: an appropriate definition of dyspepsia; adequate sample size; dyspeptic subjects and controls sampled from the general population; and results adjusted for potential confou...
متن کاملShould we eradicate Helicobacter pylori in non-ulcer dyspepsia?
EPIDEMIOLOGICAL STUDIES Forty two epidemiological studies compared the prevalence of H pylori infection in dyspeptic patients and asymptomatic controls (see website fig 1). Meaningful studies should use the following design: an appropriate definition of dyspepsia; adequate sample size; dyspeptic subjects and controls sampled from the general population; and results adjusted for potential confou...
متن کاملHelicobacter pylori infection and long term proton pump inhibitor therapy.
S hould Helicobacter pylori infection be eradicated in patients requiring maintenance proton pump inhibitor therapy for gastro-oesophageal reflux disease? This question has stimulated heated debate and contention over the past few years. The issue first came to prominence in 1996 when Kuipers et al published their study purporting to demonstrate that omeprazole accelerated the development of co...
متن کاملShould we give long-term macrolide therapy for COPD?
We would like to take this opportunity to respond to the invitation from the editors of Thorax to engage in a debate over the current place of macrolide therapy in patients with chronic obstructive pulmonary disease (COPD). We believe that the optimism imparted by Albert et al may hide harmful effects that outweigh the currently perceived benefits. In this placebocontrolled, parallel group (but...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 2001
ISSN: 0017-5749
DOI: 10.1136/gut.49.5.616